Minister of Trade and Industri, Trond Giske, is visiting Biotec Pharmacon subsidiary Marine Biochemicals on September 7th, 2010. The visit is a part of the Ministry's project to let all its employees meet with Norwegian companies all over the country.
Biotec Pharmacon will present its report for Q2 2010 on August 10th at 09:00. The presentation will be held at Thon Conference Vika Atrium, Oslo.
The presentation will also be available as webcast.
A composition patent protecting combinations of Biotec Pharmacon’s proprietary compound soluble yeast beta-glucan (SBG) as an adjuvant together with monoclonal antibodies for treatment of cancer has been granted in the U.S.